Catalog Number UNK_THERMOCOOL SF NAV |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Hemorrhage/Bleeding (1888); Cardiac Tamponade (2226)
|
Event Date 03/19/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
This complaint is from a literature source.The following literature cite has been reviewed: yang j, you l, liu m, zhang g, feng l, liu y, geng x, wu j, xie r.Impact of left atrial appendage closure combined with catheter ablation on endocrine and mechanical cardiac function in patients with atrial fibrillation.J interv cardiol.2022 mar 19;2022:3932912.Doi: 10.1155/2022/3932912.Pmid: 35360092; pmcid: pmc8957483.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc, or its employees that the report constitutes an admission that the product, biosense webster inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer¿s reference number: (b)(4).
|
|
Event Description
|
This complaint is from a literature source.The following literature cite has been reviewed: yang j, you l, liu m, zhang g, feng l, liu y, geng x, wu j, xie r.Impact of left atrial appendage closure combined with catheter ablation on endocrine and mechanical cardiac function in patients with atrial fibrillation.J interv cardiol.2022 mar 19;2022:3932912.Doi: 10.1155/2022/3932912.Pmid: 35360092; pmcid: pmc8957483.Objective/methods/study data: background: the combined procedure of left atrial appendage closure (laac) and catheter ablation (ca) is a safe and feasible therapy to treat patients with atrial fibrillation (af).However, the effect of the combined procedure on cardiac function remains unclear.& is study aimed to investigate the changes in endocrine and mechanical function of the heart following the combined procedure.Methods: this retrospective study included 62 consecutive patients who underwent the combined procedure of af ablation and watchman laac and 62 sex and age-matched patients who only received af ablation.During follow-up, patients were examined for brain natriuretic peptide (bnp) levels to represent endocrine cardiac function.Mechanical cardiac function was assessed during echocardiographic examination.No significant difference was observed between the two groups.Conclusions: the combined procedure of laac and ca significantly improved the endocrine and mechanical function of the heart.Compared to simple ca, based on ca with laac intervention, it does not significantly change la endocrine function but may lead to a decline in the la reservoir function.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: thermocool smart-touch, biosense webster other biosense webster concomitant devices that were also used in this study: carto 3, biosense webster.Lasso® nav eco, biosense webster.Non-biosense webster concomitant devices that were also used in this study: watchman, boston scientific,(b)(6), usa adverse event(s) and provided interventions: there were two adverse events reported in the literature article: one patient had pericardial effusion requiring drainage.One patient experienced bleeding.
|
|
Search Alerts/Recalls
|
|